Now showing items 1-3 of 3
Reduction in Mortality Risk With Opioid Agonist Therapy: a Systematic Review and Meta‐Analysis
Introduction Opioid agonist therapies are effective medications that can greatly improve the quality of life of individuals with opioid use disorder. However, there is significant uncertainty about the risks of cause‐specific ...
Pharmacological treatment for insomnia in patients with major depressive disorder
(Taylor and Francis, 2019-05-16)
Introduction: Insomnia in Major Depressive Disorder (MDD) is highly prevalent and associated with increased suffering and functional impairment. Effective, evidence-based treatments for insomnia in MDD are an unmet need ...
Steroids and antidepressant response
The recent meta-analytic review of trials involving anti-inflammatory agents to treat or to supplement treatment of patients with major depressive disorder (MDD) or depressive symptoms by Köhler-Forsberg and colleagues  ...